InsidersTradesSigma
SynAct Pharma AB Stock: price and insider trades · Finland · FIN-FSA
Track the SynAct Pharma AB share price and the full management transaction log of the company, a listed equity based in Finland. Shares trade on FI FI, under the oversight of FIN-FSA. Operating in the Health Care sector, SynAct Pharma AB has recorded 1 reports. Market capitalisation: €772.8m. The latest transaction was filed on 9 March 2026 (Purchase). Among the most active insiders: Mads Liebach Bjerregaard. The full history is accessible without an account.
1
Insider Decl.
0
Thresholds
€2,517
1 ops.
Buy Volume
·
0 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate SynAct Pharma AB Strong Buy (bullish), based on 2 analysts. Average price target: SEK 34.65.
20Σ signal
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 9 March 2026
Declarations1 total
●
Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutives
1,500 shares@ €1.6780.0003% mcap100.0% of flowAktieFI:A003W835-1
Ideal exit: 30 Nov 2026 (T+270)
1 of 1 declaration